Inovio Pharmaceuticals Inc. Stock Advances 9.9%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. advanced 9.9% to $1.22 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,861.06 and the Dow Jones Industrial Average falling 0.9% to 50,906.05.

The stock's rise snapped a five-day losing streak.

Inovio Pharmaceuticals Inc. closed 55.1% below its 52-week high of $2.72, which the company reached on December 17th.

The stock outperformed some of its peers, as Johnson & Johnson fell 1.1% to $264.74, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.70% to $28.52.

Trading volume totaled 2.6 million, compared to the 50-day average of 4.4 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 30, 2026 16:33 ET (20:33 GMT)